Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9134
|
pubmed:dateCreated |
1998-11-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
352
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1119
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9798593-Adult,
pubmed-meshheading:9798593-Anticonvulsants,
pubmed-meshheading:9798593-Diethylcarbamazine,
pubmed-meshheading:9798593-Dose-Response Relationship, Drug,
pubmed-meshheading:9798593-Drug Interactions,
pubmed-meshheading:9798593-Female,
pubmed-meshheading:9798593-Fructose,
pubmed-meshheading:9798593-Hepatic Encephalopathy,
pubmed-meshheading:9798593-Humans
|
pubmed:year |
1998
|
pubmed:articleTitle |
Topiramate and fulminant liver failure.
|
pubmed:publicationType |
Letter,
Case Reports
|